Command Palette

Search for a command to run...

Clinical Trials · NCT01484873

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

CompletedPhase 2Exenatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Vanderbilt University Medical Center
Enrollment
10
Start date
Jun 2012
Locations
1 site, United States
Primary endpoint
Body Weight (kg)
View Exenatide compound reference